Impact of Azelnidipine in reducing urinary albumin excretion and carotid atherosclerosis in type 2 diabetes patients: BOAT 2 study Review Dr. Prem Aggarwal15 Dec 2020 12:45 PM ISTHypertension and Diabetes Mellitus are the global health burden and strong risk factors for coronary artery disease (1). Impaired glucose tolerance...
Azelnidipine versus Amlodipine in hypertensive diabetics with albuminuria: Review Dr. Prem Aggarwal27 Nov 2020 12:45 PM ISTHypertension is common among diabetics and those who have chronic kidney disease. Both hypertension and diabetes are associated with increased...
Hypertension in Diabetes: Considering Therapies which Optimise Kidney Protection Dr Sujoy Ghosh20 Nov 2020 11:25 AM ISTHypertension and Diabetes remain the top two causes of End-Stage Renal Disease (ESRD) (1). Hence, it seems clinically appropriate to establish that...
Role of Azelnidipine on management of BP in hypertensive Diabetics: Review Dr. Prem Aggarwal4 Nov 2020 11:09 AM ISTHypertensive patients with type 2 diabetes carry a high cardiovascular risk. Most patients with hypertension and diabetes face higher mortality due to...
BPLTTC: Using Antihypertensive agents as risk modifiers for prevention of CV events irrespective of baseline criteria: Scope of Amlodipine Dr. Prem Aggarwal13 Oct 2020 12:17 PM ISTHypertension, a prominent cause of premature mortality, affects ~1.13 billion people worldwide, though blood pressure (BP) control rates remain dismal...
Gliclazide modified release better second-line treatment than sitagliptin for type 2 diabetes patients on Metformin- Study Hina Zahid9 Oct 2020 9:44 AM ISTUK: Gliclazide modified release (MR) is more effective in reducing blood sugar levels than sitagliptin in type 2 diabetes (T2D) patients already...
